Abstract
We have investigated the effect of a range of drugs (some commonly coadministered with zidovudine [ZDV] to human immunodeficiency virus-positive patients) on intracellular phosphorylation of ZDV by stimulated peripheral blood mononuclear cells, Molt 4 cells, and U937 cells in vitro. Of the drugs tested (azoles, antiviral agents, antibiotics, and anticancer agents), only doxorubicin and ribavirin caused inhibition of anabolite formation as measured by high-performance liquid chromatography. This in vitro approach may provide important leads to potential interactions at the phosphorylation level in patients with human immunodeficiency virus disease. It is reassuring that so many commonly administered drugs do not alter ZDV phosphorylation.
Full Text
The Full Text of this article is available as a PDF (216.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnér E. S., Valentin A., Eriksson S. Thymidine and 3'-azido-3'-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways. J Biol Chem. 1992 Jun 5;267(16):10968–10975. [PubMed] [Google Scholar]
- Baba M., Pauwels R., Balzarini J., Herdewijn P., De Clercq E., Desmyter J. Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. Antimicrob Agents Chemother. 1987 Oct;31(10):1613–1617. doi: 10.1128/aac.31.10.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barry M., Wild M., Veal G., Back D., Breckenridge A., Fox R., Beeching N., Nye F., Carey P., Timmins D. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers. AIDS. 1994 Aug;8(8):F1–F5. doi: 10.1097/00002030-199408000-00002. [DOI] [PubMed] [Google Scholar]
- Brass C., Galgiani J. N., Blaschke T. F., Defelice R., O'Reilly R. A., Stevens D. A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 Jan;21(1):151–158. doi: 10.1128/aac.21.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burger D. M., Meenhorst P. L., Koks C. H., Beijnen J. H. Drug interactions with zidovudine. AIDS. 1993 Apr;7(4):445–460. doi: 10.1097/00002030-199304000-00001. [DOI] [PubMed] [Google Scholar]
- Burger D. M., Meenhorst P. L., Koks C. H., Beijnen J. H. Pharmacokinetic interaction between rifampin and zidovudine. Antimicrob Agents Chemother. 1993 Jul;37(7):1426–1431. doi: 10.1128/aac.37.7.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cheng Y. C., Dutschman G., Fox J. J., Watanabe K. A., Machida H. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob Agents Chemother. 1981 Sep;20(3):420–423. doi: 10.1128/aac.20.3.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cretton E. M., Xie M. Y., Bevan R. J., Goudgaon N. M., Schinazi R. F., Sommadossi J. P. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Mol Pharmacol. 1991 Feb;39(2):258–266. [PubMed] [Google Scholar]
- Eagling V. A., Howe J. L., Barry M. J., Back D. J. The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267–276. doi: 10.1016/0006-2952(94)90097-3. [DOI] [PubMed] [Google Scholar]
- Eksborg S., Ehrsson H., Andersson I. Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. J Chromatogr. 1979 Dec 1;164(4):479–486. doi: 10.1016/s0378-4347(00)81550-9. [DOI] [PubMed] [Google Scholar]
- Field A. K., Davies M. E., DeWitt C., Perry H. C., Liou R., Germershausen J., Karkas J. D., Ashton W. T., Johnston D. B., Tolman R. L. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4139–4143. doi: 10.1073/pnas.80.13.4139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fletcher C., Sawchuk R., Chinnock B., de Miranda P., Balfour H. H., Jr Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther. 1986 Sep;40(3):281–286. doi: 10.1038/clpt.1986.177. [DOI] [PubMed] [Google Scholar]
- Gao W. Y., Shirasaka T., Johns D. G., Broder S., Mitsuya H. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest. 1993 May;91(5):2326–2333. doi: 10.1172/JCI116463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall K. W., Nightingale C. H., Gibaldi M., Nelson E., Bates T. R., DiSanto A. R. Pharmacokinetics of erythromycin in normal and alcoholic liver disease subjects. J Clin Pharmacol. 1982 Jul;22(7):321–325. doi: 10.1002/j.1552-4604.1982.tb02682.x. [DOI] [PubMed] [Google Scholar]
- Kremers P., Duvivier J., Heusghem C. Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. J Clin Pharmacol. 1974 Feb-Mar;14(2):112–117. doi: 10.1002/j.1552-4604.1974.tb02300.x. [DOI] [PubMed] [Google Scholar]
- Laskin O. L., Longstreth J. A., Hart C. C., Scavuzzo D., Kalman C. M., Connor J. D., Roberts R. B. Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther. 1987 May;41(5):546–555. doi: 10.1038/clpt.1987.70. [DOI] [PubMed] [Google Scholar]
- Morse G. D., Shelton M. J., O'Donnell A. M. Comparative pharmacokinetics of antiviral nucleoside analogues. Clin Pharmacokinet. 1993 Feb;24(2):101–123. doi: 10.2165/00003088-199324020-00002. [DOI] [PubMed] [Google Scholar]
- Mukherji E., Au J. L., Mathes L. E. Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells. Antimicrob Agents Chemother. 1994 Jul;38(7):1573–1579. doi: 10.1128/aac.38.7.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qian M., Chandrasena G., Ho R. J., Unadkat J. D. Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells. Antimicrob Agents Chemother. 1994 Oct;38(10):2398–2403. doi: 10.1128/aac.38.10.2398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith D., van de Velde V., Woestenborghs R., Gazzard B. G. The pharmacokinetics of oral itraconazole in AIDS patients. J Pharm Pharmacol. 1992 Jul;44(7):618–619. doi: 10.1111/j.2042-7158.1992.tb05478.x. [DOI] [PubMed] [Google Scholar]
- Sommadossi J. P. Nucleoside analogs: similarities and differences. Clin Infect Dis. 1993 Feb;16 (Suppl 1):S7–15. doi: 10.1093/clinids/16.supplement_1.s7. [DOI] [PubMed] [Google Scholar]
- Stagg M. P., Cretton E. M., Kidd L., Diasio R. B., Sommadossi J. P. Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine. Clin Pharmacol Ther. 1992 Jun;51(6):668–676. doi: 10.1038/clpt.1992.79. [DOI] [PubMed] [Google Scholar]
- Stern J. J., Hartman B. J., Sharkey P., Rowland V., Squires K. E., Murray H. W., Graybill J. R. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med. 1988 Oct;85(4):477–480. doi: 10.1016/s0002-9343(88)80081-0. [DOI] [PubMed] [Google Scholar]
- Szebeni J., Patel S. S., Hung K., Wahl L. M., Weinstein J. N. Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells. Antimicrob Agents Chemother. 1991 Jan;35(1):198–200. doi: 10.1128/aac.35.1.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taburet A. M., Katlama C., Blanshard C., Zorza G., Gazzard D., Dohin E., Gazzard B. G., Frostegard C., Singlas E. Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients. Antimicrob Agents Chemother. 1992 Sep;36(9):1821–1824. doi: 10.1128/aac.36.9.1821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Veal G. J., Wild M. J., Barry M. G., Back D. J. Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells. Br J Clin Pharmacol. 1994 Oct;38(4):323–328. doi: 10.1111/j.1365-2125.1994.tb04361.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vogt M. W., Hartshorn K. L., Furman P. A., Chou T. C., Fyfe J. A., Coleman L. A., Crumpacker C., Schooley R. T., Hirsch M. S. Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science. 1987 Mar 13;235(4794):1376–1379. doi: 10.1126/science.2435003. [DOI] [PubMed] [Google Scholar]
- Whitley R. J., Blum M. R., Barton N., de Miranda P. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med. 1982 Jul 20;73(1A):165–171. doi: 10.1016/0002-9343(82)90084-5. [DOI] [PubMed] [Google Scholar]